News

Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.

Patients with chronic back and leg pain may be able to forgo the use of prescription painkillers thanks to a new treatment that has been shown to provide long-lasting analgesia.

Americans undergo approximately 90,0000 ventral hernia repairs annually. Those who contract methicillin-resistant staphylococcus aureus infections face a difficult course, and clinicians often struggle to eradicate this tenacious infection.

The latest research has confirmed bariatric surgery or lifestyle modifications could significantly diminish levels of nonalcoholic steatohepatitis (NASH) in obese patients.

Unless a vaccine is considered "perfect", it could be causing more harm than good.

At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.

Results from a long-term trial indicate that sublingual immunotherapy, though quite safe, is rarely fully effective in people with severe peanut allergies.

Researchers have long known that single men tend to have more testosterone than comparable men in long-term relationships, but what about men in new relationships? A new study finds that testosterone generally remains at "single-man" levels until couples have been dating for more than a year.

An increasing number of patients worldwide with severe pemphigus vulgaris (PV) are showing little or no response with conventional steroid treatment; however, a new treatment may become an option.

New research suggests that the relative ease of using novel oral anticoagulants may be spurring more patients with atrial fibrillation to try anticoagulation and stick with it.

A recently completed Phase III trial – called PREEMPT – established the efficacy and safety of onabotulinumtoxinA (marketed by Allergan under the brand name Botox®) in treating chronic migraine. Following those results, a new long-term trial is currently underway to analyze some of the clinical questions raised but not answered in PREEMPT.

The skin disease scabies is like the television show Grey's Anatomy: It's been around forever, and you may, every now and again, find yourself wondering, "Is that thing still around?" In both cases, unfortunately, the answer is a definitive "yes."

Studies have shown that major depressive disorder (MDD) has a strong link to genetic factors, and many clinicians and researchers believe the same to be true for obesity.

A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.

Evidence continues to emerge that biologics-in combination with DMARDS-offer a solid line of defense for patients with rheumatoid arthritis at risk of rapid disease progression .

Study results show that mood, whether positive or negative, may impact the discomfort associated with rheumatoid arthritis.

Compared with the general population, patients with atopic dermatitis are significantly more susceptible to Staphyloccocus aureus colonization and skin infections.

Patients with idiopathic generalized epilepsies (IGE) can also have focal seizure symptoms. A team of Australian researchers has added some findings that indicate which patients are more likely to have both types of seizures

Psychedelic drugs can reduce negative psychological effects and suicidal thinking, planning, or attempts, according to John Hopkins Medicine researchers.

Does timing really make an impact when it comes to treating back pain? A new study weighed in on the importance early initiation of therapy in this patient population.

July 28 is World Hepatitis Day. The organizers of the awareness campaign are using a variety of channels, including social media, to educate and inform patients and clinicians about hepatitis prevention and treatment.

A new sub-analysis of data from the trial known as ROCKET-AF shows that rivaroxaban (Xarelto/Janssen) works as well in patients who have both non-valvular atrial fibrillation (AF) and diabetes as in AF patients without diabetes.

Analysis of a population-based cohort indicates that patients with psoriasis and psoriatic arthritis face an elevated risk of developing heart arrhythmias such as atrial fibrillation.

A new investigation of the molecular and cellular mechanisms that produce diabetes may explain the strong association between cystic fibrosis and pancreatic complications.

With obesity on the rise, bringing with it an increased risk of diabetes, cardiovascular disease, and other conditions, food labels may soon get a facelift.

In just 15 minutes an Ebola fingerstick blood test can accurately determine whether a patient is infected with the virus, a team from the Viral Hemorrhagic Fever Consortium reported.

While alternative and complimentary medicine make their way closer to the mainstream there are still some areas of concern with using them while treating hepatitis C. There have also been questions raised about the costs associated with using new medications to treat the disease.

A clinical trial is evaluating the use of the Kokoro app to deliver a smartphone-based CBT program to patients being treated for depression.

Awareness-raising day included events throughout the country aimed at reducing the high incidence of infection among people in black communities.

Patients with hepatitis C may not be diagnosed with the condition until their liver damage has progressed to the point of needing a transplant. They may also be suffering from renal failure which requires a different look at treatment options in order to improve overall health.